Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. covers the period of September 2020. The document serves as a notice regarding the scheduling of an Annual and Extraordinary General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Corporate Actions
The Company announced it will hold its Annual and Extraordinary General Meeting on October 13, 2020, at 10:00 a.m. Israel time. The meeting will be held at the offices of Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. in Tel-Aviv, Israel.
- Exhibit 99.1: Notice and Proxy Statement detailing proposals to be voted upon and voting procedures.
- Exhibit 99.2: Proxy Card for holders of ordinary shares.
- Exhibit 99.3: Voting Instruction Card for holders of American Depositary Shares (ADSs) to instruct Bank of New York Mellon.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the record date for shareholder eligibility, which is not explicitly stated in this summary text.
- Review the voting instructions for ADS holders to ensure proper submission via Bank of New York Mellon.
- Note that this filing does not contain updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.